JUN 27, 2022 8:30 AM PDT

Potential Gene Targets Identified for Treating Deafness

WRITTEN BY: Annie Lennon

Researchers have identified three mutations of the MINAR2 gene that are linked to deafness. They say that the mutations may hold promise as potential targets for future treatments for deafness. The corresponding study was published in PNAS

The researchers behind the study have been studying the genetic underpinnings of deafness for over two decades. During this time, they have created a biorepository with a genomic sequencing database of deafness-associated gene mutations from families all over the world. 

For the present study, the researchers set out by sequencing a Turkish family’s genome in an attempt to identify genes already linked to deafness. As their search yielded no results, they then conducted whole-genome sequencing to identify new genes or anything they missed in the initial test. 

In doing so, they identified variants of the MINAR2 gene, a newly described gene in research literature whose function is still relatively unknown. After identifying the MINAR2 variations, the researchers then searched their database and found another family with a different mutation of the same gene. Further investigation yielded three different MINAR2 mutations causing deafness in 13 people from four families. 

To understand more about MINAR2's function, the researchers turned to mouse models of the gene. From these, they noted that MINAR2 is expressed in the mouse inner ear, and is mainly present in hair cells and other areas critical to hearing. Hair cells convert sound into electrical signals, which are then sent to the brain and interpreted. As such, children who are born deaf have few if any living hair cells. 

In further experiments, the researchers knocked out MINAR2 function in mouse models. In doing so, they found that mice presented with rapidly progressive hearing loss linked to a gradual reduction of outer har cells as they aged. The researchers thus concluded that MINAR2 is essential for hearing in humans and mice and that its disruption leads to hearing loss. 

The researchers say that their findings may provide opportunities to develop genetic therapies that could one day prevent hearing loss. 

“What is surprising and promising for potential intervention is that, when we looked at the hair cells in our mouse model, they are alive until a certain age,” said Mustafa Tekin, M.D., a professor in the Dr. John T. Macdonald Foundation Department of Human Genetics at the University of Miami, and senior author on the paper “That gives us a window of opportunity to provide treatment. We could insert the normal gene and potentially restore hearing.” 

 

Sources: Neuroscience News, PNAS

 

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUN 26, 2022
Drug Discovery & Development
Vitamin Supplements are a 'Waste of Money' for Healthy Americans
JUN 26, 2022
Vitamin Supplements are a 'Waste of Money' for Healthy Americans
The US Preventive Services Task Force (USPSTF) recommends against using beta carotene or vitamin E supplements to preven ...
JUL 11, 2022
Cancer
Boosting CAR T Cell Therapy with TIGIT Blockade
JUL 11, 2022
Boosting CAR T Cell Therapy with TIGIT Blockade
Chimeric antigen receptor (CAR) T Cell therapy has emerged as a promising immunotherapeutic approach to treat blood canc ...
JUL 13, 2022
Neuroscience
Listen Up: Sound Provides Pain Relief
JUL 13, 2022
Listen Up: Sound Provides Pain Relief
People often think of pharmaceutical treatments and meditation to ease physical pain, but pain can be alleviated with mu ...
JUL 19, 2022
Drug Discovery & Development
Experimental Cancer Drug Regrows Nerves in Spinal Cord Injury
JUL 19, 2022
Experimental Cancer Drug Regrows Nerves in Spinal Cord Injury
An experimental cancer drug can regenerate damaged nerves following spinal trauma in mice and rats. The corresponding re ...
JUL 23, 2022
Drug Discovery & Development
No Evidence for Depression and Serotonin Activity Link
JUL 23, 2022
No Evidence for Depression and Serotonin Activity Link
A new review study found that there is no clear evidence that serotonin levels or serotonin activity are responsible for ...
AUG 11, 2022
Clinical & Molecular DX
New Tuberculosis Vaccine Enters Phase III Clinical Trial
AUG 11, 2022
New Tuberculosis Vaccine Enters Phase III Clinical Trial
Tuberculosis is a disease caused by the bacterium Mycobacterium tuberculosis. It is spread through the air when a person ...
Loading Comments...